INKT
insider transactionsMiNK Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-3.5K
0 buy · 3.5K sell
Net value · 365d
-$46.6K
$0 in · $46.6K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
8
0 buy · 3.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Director
$12.8K
1.0K sh · $12.80
Own -4%
-
Sell·S
Director
$6.3K
500 sh · $12.68
Own -2%
-
Grant·A
Director
$17.8K
1.4K sh · $12.38
Own +7%
-
Grant·A
Director
$14.0K
1.1K sh · $12.38
Own +5%
-
Grant·A
Director
$13.5K
1.1K sh · $12.38
Own +46%
-
Grant·A
Director
$17.9K
1.4K sh · $12.38
Own +3%
-
Grant·A
Director
$16.3K
1.3K sh · $12.38
Own +6%
-
Sell·S
Director
$4.6K
300 sh · $15.28
Own -1%
-
Sell·S
Director
$7.8K
500 sh · $15.57
Own -2%
-
Sell·S
Director
$7.7K
500 sh · $15.30
Own -2%
-
Sell·S
Director
$2.0K
200 sh · $10.17
Own -1%
-
Grant·A
Director
$17.8K
1.6K sh · $10.90
Own +8%
-
Grant·A
Director
$14.0K
1.3K sh · $10.90
Own +6%
-
Grant·A
Director
$13.5K
1.2K sh · $10.90
Own +110%
-
Grant·A
Director
$17.9K
1.6K sh · $10.90
Own +3%
-
Grant·A
Director
$16.3K
1.5K sh · $10.90
Own +7%
-
Sell·S
Director
$1.1K
100 sh · $10.83
Own -0%
-
Sell·S
Director
$4.3K
400 sh · $10.86
Own -2%
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Buell Jennifer KEY
Chief Executive Officer
$0
50.0K sh
Own New
-
Grant·A
Buell Jennifer KEY
Chief Executive Officer
$350.0K
31.5K sh · $11.12
Own +86%
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Grant·A
Director
$0
5.4K sh
Own New
-
Other·F
Buell Jennifer KEY
Chief Executive Officer
$111.5K
10.0K sh · $11.12
Own -15%
-
Grant·A
Director
$12.5K
1.1K sh · $11.09
Own New
-
Grant·A
Director
$16.3K
1.5K sh · $11.09
Own +8%
-
Grant·A
Director
$13.5K
1.2K sh · $11.09
Own +7%
-
Grant·A
Director
$14.0K
1.3K sh · $11.09
Own +7%
-
Grant·A
Director
$17.8K
1.6K sh · $11.09
Own +8%
-
Grant·A
Director
$17.9K
1.6K sh · $11.09
Own +3%
-
Grant·A
Director
$0
4.2K sh
Own New
-
Other·F
Buell Jennifer KEY
Chief Executive Officer
$82.2K
5.4K sh · $15.36
Own -13%
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Director
$0
3.2K sh
Own New
-
Grant·A
Buell Jennifer KEY
Chief Executive Officer
$0
50.0K sh
Own New
-
Grant·A
Buell Jennifer KEY
Chief Executive Officer
$280.0K
18.2K sh · $15.36
Own +77%
-
Grant·A
Director
$17.8K
1.3K sh · $13.86
Own +7%
-
Grant·A
Director
$13.5K
975 sh · $13.86
Own +6%
-
Grant·A
Director
$14.0K
1.0K sh · $13.86
Own +6%
-
Grant·A
Director
$17.9K
1.3K sh · $13.86
Own +3%
-
Grant·A
Director
$16.3K
1.2K sh · $13.86
Own +7%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Ryan Barbara | Sell S | 1.0K | $12.8K |
| Jun 4, 2026 | Ryan Barbara | Sell S | 500 | $6.3K |
| Jun 1, 2026 | Ryan Barbara | Grant A | 1.4K | $17.8K |
| Jun 1, 2026 | WIINBERG ULF | Grant A | 1.1K | $14.0K |
| Jun 1, 2026 | Holcomb John Bradley | Grant A | 1.1K | $13.5K |
| Jun 1, 2026 | Corvese Brian | Grant A | 1.4K | $17.9K |
| Jun 1, 2026 | Behner Peter | Grant A | 1.3K | $16.3K |
| Mar 10, 2026 | Ryan Barbara | Sell S | 300 | $4.6K |
| Mar 10, 2026 | Ryan Barbara | Sell S | 500 | $7.8K |
| Mar 10, 2026 | Ryan Barbara | Sell S | 500 | $7.7K |
| Mar 9, 2026 | Ryan Barbara | Sell S | 200 | $2.0K |
| Mar 2, 2026 | Ryan Barbara | Grant A | 1.6K | $17.8K |
| Mar 2, 2026 | WIINBERG ULF | Grant A | 1.3K | $14.0K |
| Mar 2, 2026 | Holcomb John Bradley | Grant A | 1.2K | $13.5K |
| Mar 2, 2026 | Corvese Brian | Grant A | 1.6K | $17.9K |
| Mar 2, 2026 | Behner Peter | Grant A | 1.5K | $16.3K |
| Mar 2, 2026 | Ryan Barbara | Sell S | 100 | $1.1K |
| Feb 27, 2026 | Ryan Barbara | Sell S | 400 | $4.3K |
| Jan 2, 2026 | Behner Peter | Grant A | 5.4K | $0 |
| Jan 2, 2026 | Buell Jennifer KEY | Grant A | 50.0K | $0 |
| Jan 2, 2026 | Buell Jennifer KEY | Grant A | 31.5K | $350.0K |
| Jan 2, 2026 | Ryan Barbara | Grant A | 5.4K | $0 |
| Jan 2, 2026 | Corvese Brian | Grant A | 5.4K | $0 |
| Jan 2, 2026 | WIINBERG ULF | Grant A | 5.4K | $0 |
| Jan 2, 2026 | Buell Jennifer KEY | Other F | 10.0K | $111.5K |
| Dec 1, 2025 | Holcomb John Bradley | Grant A | 1.1K | $12.5K |
| Dec 1, 2025 | Behner Peter | Grant A | 1.5K | $16.3K |
| Dec 1, 2025 | Kadlec Robert Peter | Grant A | 1.2K | $13.5K |
| Dec 1, 2025 | WIINBERG ULF | Grant A | 1.3K | $14.0K |
| Dec 1, 2025 | Ryan Barbara | Grant A | 1.6K | $17.8K |
| Dec 1, 2025 | Corvese Brian | Grant A | 1.6K | $17.9K |
| Sep 23, 2025 | Holcomb John Bradley | Grant A | 4.2K | $0 |
| Sep 9, 2025 | Buell Jennifer KEY | Other F | 5.4K | $82.2K |
| Sep 9, 2025 | Ryan Barbara | Grant A | 3.2K | $0 |
| Sep 9, 2025 | Behner Peter | Grant A | 3.2K | $0 |
| Sep 9, 2025 | Kadlec Robert Peter | Grant A | 3.2K | $0 |
| Sep 9, 2025 | Corvese Brian | Grant A | 3.2K | $0 |
| Sep 9, 2025 | WIINBERG ULF | Grant A | 3.2K | $0 |
| Sep 9, 2025 | Buell Jennifer KEY | Grant A | 50.0K | $0 |
| Sep 9, 2025 | Buell Jennifer KEY | Grant A | 18.2K | $280.0K |
| Sep 2, 2025 | Ryan Barbara | Grant A | 1.3K | $17.8K |
| Sep 2, 2025 | Kadlec Robert Peter | Grant A | 975 | $13.5K |
| Sep 2, 2025 | WIINBERG ULF | Grant A | 1.0K | $14.0K |
| Sep 2, 2025 | Corvese Brian | Grant A | 1.3K | $17.9K |
| Sep 2, 2025 | Behner Peter | Grant A | 1.2K | $16.3K |
About INKT insider trading
This page tracks insider transactions for MiNK Therapeutics, Inc. (INKT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.